Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ce |
RCV000488099 | SCV000575327 | likely benign | not provided | 2023-10-01 | criteria provided, single submitter | clinical testing | COL6A2: BP4 |
Eurofins Ntd Llc |
RCV000488099 | SCV000702587 | uncertain significance | not provided | 2016-10-12 | criteria provided, single submitter | clinical testing | |
Invitae | RCV001452859 | SCV001656536 | likely benign | Bethlem myopathy 1A | 2023-10-13 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000488099 | SCV001764262 | uncertain significance | not provided | 2021-02-10 | criteria provided, single submitter | clinical testing | Reported as a variant of uncertain significance in the heterozygous state in a patient with suspected LGMD; however, no additional information was provided (Nallamilli et al., 2018); In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 30564623) |
Revvity Omics, |
RCV000488099 | SCV003832442 | uncertain significance | not provided | 2023-01-04 | criteria provided, single submitter | clinical testing |